Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels (TRANSFORM II)

  • End date
    Nov 30, 2028
  • participants needed
  • sponsor
    Fondazione Ricerca e Innovazione Cardiovascolare ETS
Updated on 15 June 2022
percutaneous coronary intervention


International, multicentric, prospective, investigator-driven, open-label, randomized (1:1) clinical trial to observe and evaluate the efficacy, of Magic Touch Sirolimus Coated Balloon (SCB) compared to one of the gold standard treatment for native vessel disease (everolimus-eluting stent, EES).


The purpose of TRANSFORM II study is to observe and evaluate the efficacy of Magic Touch SCB compared to the gold standard treatment for native vessel disease, namely new-generation everolimus-eluting Drug Eluting Stent (DES). Given the inherent and recognized limitations of stents in native vessels with diameter <3 mm, only patients with coronary vessels up to 3 mm of diameter (by visual estimation) will be enrolled in this study.

Condition Coronary Artery Disease, Coronary Artery Stenosis
Treatment Sirolimus coated balloon, Everolimus Eluting Stent
Clinical Study IdentifierNCT04893291
SponsorFondazione Ricerca e Innovazione Cardiovascolare ETS
Last Modified on15 June 2022


Yes No Not Sure

Inclusion Criteria

age >18 years
all patients with a clinical indication to Percutaneous Coronary Intervention (PCI) (stable coronary artery disease or acute coronary syndromes)
native coronary artery lesion in a vessel with diameter >2.0 mm and ≦3.0 mm at visual estimation
maximum lesion length: 40 mm
informed consent to participate in the study

Exclusion Criteria

patients with known (and untreatable) hypersensitivity or contraindication to aspirin, heparin, clopidogrel, prasugrel, ticagrelor, sirolimus or contrast media, which cannot be adequately pre-medicated
patients participating in another clinical study
subject is a woman who is pregnant or nursing (pregnancy test, either urine or blood test must be performed within 7 days prior to the index procedure in woman of child-bearing potential, and must not commit to initiating a pregnancy for 12 weeks after implantation, using effective contraception)
creatinine clearance <30 ml/min
left ventricular ejection fraction <30%
life expectancy <12 months
ST-elevation myocardial infarction in the previous 48 hours
visible thrombus at lesion site
culprit lesion stenosis >99% and/or Thrombolysis In Myocardial Infarction (TIMI) flow <2
target lesion/vessel with any of the following characteristics
concomitant PCI at the same vessel with any device (vessels are considered: left anterior descending, circumflex or right coronary artery)
pre-dilatation of the target lesion not performed or not successful (residual stenosis >30%)
severe calcification of the target vessel, at lesion site but also proximally
highly tortuous vessel which could impair device delivery to the lesion site following Investigator's judgement
previous stent implantation at target vessel (left anterior descending artery; circumflex artery; right coronary artery)
bifurcation lesion where side branch treatment is anticipated
left main stem stenosis >50%
target lesion is in left main stem
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note